logo
NasdaqGS:LEGN logo

Legend Biotech Community

NasdaqGS:LEGN Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 24 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

LEGN logo
Legend Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 21 Analysts

Expanding Facilities In Belgium And New Jersey Will Boost Reach

Key Takeaways Expanded manufacturing and outpatient approval are set to increase supply and streamline distribution, potentially boosting net margins and revenue. Strategic international market expansion and pipeline diversification aim to enhance market share and future revenue.
View narrative
US$77.99
FV
57.5% undervalued intrinsic discount
48.40%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
1 day ago author updated this narrative